ACS Critical Pathways Teleconferences Archived Teleconferences
Wednesday, April 14, 2010 - 12:00 Noon CME/CNE
Agenda Highlight:
Report From the American College of Cardiology (ACC) Annual Scientific Session
Faculty:
Gregg C. Fonarow, MD
Eliot Corday Professor of Medicine and Cardiovascular Science
Director, Ahmanson-UCLA Cardiomyopathy Center
UCLA Division of Cardiology
UCLA Medical Center
Los Angeles, California
Wednesday, January 13, 2010 - 3:00 PM CME/CNE
Agenda Highlight:
Insights From the NCDR: What Are We Doing in "Real" Practice and How Can We Improve?
Faculty:
Gregg C. Fonarow, MD
Eliot Corday Professor of Medicine and Cardiovascular Science
Director, Ahmanson-UCLA Cardiomyopathy Center
UCLA Division of Cardiology
UCLA Medical Center
Los Angeles, California
Wednesday, December 2, 2009 CME/CNE
Agenda Highlight:
Report From the American Heart Association (AHA) Scientific Sessions 2009
Faculty:
Gregg C. Fonarow, MD
Eliot Corday Professor of Medicine and Cardiovascular Science
Director, Ahmanson-UCLA Cardiomyopathy Center
UCLA Division of Cardiology
UCLA Medical Center
Los Angeles, California
Wednesday, October 14, 2009 CME/CNE
Agenda Highlight:
Report From Transcatheter Cardiovascular Therapeutics (TCT) 2009
Faculty:
Gregg C. Fonarow, MD
Eliot Corday Professor of Medicine and Cardiovascular Science
Director, Ahmanson-UCLA Cardiomyopathy Center
UCLA Division of Cardiology
UCLA Medical Center
Los Angeles, California
Wednesday, September 23, 2009 CME/CNE
Agenda Highlight:
Report From the European Society of Cardiology (ESC) Congress 2009
Faculty:
Christopher P. Cannon, MD
Associate Professor of Medicine
Harvard Medical School
Senior Investigator, TIMI Study Group
Associate Physician, Cardiovascular Division
Brigham and Women’s Hospital
Boston, Massachusetts
Wednesday, August 12, 2009 CME/CNE
Agenda Highlight:
Sex-Related Differences in ACS Care and Outcomes
Faculty:
Christopher P. Cannon, MD
Associate Professor of Medicine
Harvard Medical School
Senior Investigator, TIMI Study Group
Associate Physician, Cardiovascular Division
Brigham and Women’s Hospital
Boston, Massachusetts
Wednesday, July 8, 2009 CME/CNE
Agenda Highlight:
Weekday Versus Weekend Admission for ACS: Is There a Difference in Quality of Care?
Faculty:
Gregg C. Fonarow, MD
Eliot Corday Professor of Medicine and Cardiovascular Science
Director, Ahmanson-UCLA Cardiomyopathy Center
UCLA Division of Cardiology
UCLA Medical Center
Los Angeles, California
Wednesday, June 10, 2009 CME/CNE
Agenda Highlight:
Dosing Matters: Adjusting Antithrombotic Therapy Based on Age, Weight, and Renal Function
Faculty:
Christopher P. Cannon, MD
Associate Professor of Medicine
Harvard Medical School
Senior Investigator, TIMI Study Group
Associate Physician, Cardiovascular Division
Brigham and Women’s Hospital
Boston, Massachusetts
Wednesday, May 13, 2009 CME/CNE
Agenda Highlight:
Addressing Medication Adherence in the Older Patient: The Next Frontier in Quality Improvement
Faculty:
Gregg C. Fonarow, MD
Eliot Corday Professor of Medicine and Cardiovascular Science
Director, Ahmanson-UCLA Cardiomyopathy Center
UCLA Division of Cardiology
UCLA Medical Center
Los Angeles, California
Wednesday, April 29, 2009 CME/CNE
Agenda Highlight:
Report From the American College of Cardiology 58th Annual Scientific Session
Faculty:
Christopher P. Cannon, MD
Associate Professor of Medicine
Harvard Medical School
Senior Investigator, TIMI Study Group
Associate Physician, Cardiovascular Division
Brigham and Women’s Hospital
Boston, Massachusetts
Wednesday, March 18, 2009 CME/CNE
Agenda Highlight:
Mission: Lifeline—AHA’s Banner Tool for Improving Outcomes in STEMI
Faculty:
Christopher P. Cannon, MD
Associate Professor of Medicine
Harvard Medical School
Senior Investigator, TIMI Study Group
Associate Physician, Cardiovascular Division
Brigham and Women’s Hospital
Boston, Massachusetts
Wednesday, February 11, 2009 CME/CNE
Agenda Highlight:
A RACE Against Time: Innovations to Speed Patients to Reperfusion in STEMI
Faculty:
Gregg C. Fonarow, MD
Eliot Corday Professor of Medicine and Cardiovascular Science
Director, Ahmanson-UCLA Cardiomyopathy Center
UCLA Division of Cardiology
UCLA Medical Center
Los Angeles, California
Wednesday, January 21, 2009 CME/CNE
Agenda Highlight:
New ACC/AHA Clinical Performance Measures for ACS: Are You Ready?
Faculty:
Christopher P. Cannon, MD
Associate Professor of Medicine
Harvard Medical School
Senior Investigator, TIMI Study Group
Associate Physician, Cardiovascular Division
Brigham and Women’s Hospital
Boston, Massachusetts
Wednesday, November 19, 2008 CME/CNE
Agenda Highlight:
Report From the American Heart Association (AHA) Scientific Sessions 2008
Faculty:
Gregg C. Fonarow, MD
Eliot Corday Professor of Medicine and Cardiovascular Science
Director, Ahmanson-UCLA Cardiomyopathy Center
UCLA Division of Cardiology
UCLA Medical Center
Los Angeles, California
Wednesday, October 22, 2008 CME/CNE
Agenda Highlight:
Report From Transcatheter Cardiovascular Therapeutics (TCT) 2008
Faculty:
Christopher P. Cannon, MD
Associate Professor of Medicine
Harvard Medical School
Senior Investigator, TIMI Study Group
Associate Physician, Cardiovascular Division
Brigham and Women’s Hospital
Boston, Massachusetts
Wednesday, September 10, 2008 CME/CNE
Agenda Highlight:
Report From the European Society of Cardiology (ESC) Congress 2008
Faculty:
Gregg C. Fonarow, MD
Eliot Corday Professor of Medicine and Cardiovascular Science
Director, Ahmanson-UCLA Cardiomyopathy Center
UCLA Division of Cardiology
UCLA Medical Center
Los Angeles, California
Wednesday, August 13, 2008 CME/CNE
Agenda Highlight:
Antithrombotic Agents: Balancing Bleeding and Efficacy
Faculty:
Christopher P. Cannon, MD
Associate Professor of Medicine
Harvard Medical School
Senior Investigator, TIMI Study Group
Associate Physician, Cardiovascular Division
Brigham and Women’s Hospital
Boston, Massachusetts
Wednesday, July 16, 2008 CME/CNE
Agenda Highlight:
Drug-eluting Stents in ACS: New Data
Faculty:
Gregg C. Fonarow, MD
Eliot Corday Professor of Medicine and Cardiovascular Science
Director, Ahmanson-UCLA Cardiomyopathy Center
UCLA Division of Cardiology
UCLA Medical Center
Los Angeles, California
Wednesday, June 18, 2008 CME/CNE
Agenda Highlight:
New Quality of Care Outcomes Measures
Faculty:
Christopher P. Cannon, MD
Associate Professor of Medicine
Harvard Medical School
Senior Investigator, TIMI Study Group
Associate Physician, Cardiovascular Division
Brigham and Women’s Hospital
Boston, Massachusetts
Wednesday, May 14, 2008 CME/CNE
Agenda Highlight:
Management of Hyperglycemia in ACS: Does It Matter?
Faculty:
Gregg C. Fonarow, MD
Eliot Corday Professor of Medicine and Cardiovascular Science
Director, Ahmanson-UCLA Cardiomyopathy Center
UCLA Division of Cardiology
UCLA Medical Center
Los Angeles, California
Wednesday, April 16, 2008 CME/CNE
Agenda Highlight:
Report From the American College of Cardiology 57th Annual Scientific Session
Faculty:
Christopher P. Cannon, MD
Associate Professor of Medicine
Harvard Medical School
Senior Investigator, TIMI Study Group
Associate Physician, Cardiovascular Division
Brigham and Women’s Hospital
Boston, Massachusetts
Wednesday, March 19, 2008 CME/CNE
Agenda Highlight:
New Insights From the ACTION Registry™
Faculty:
Gregg C. Fonarow, MD
Eliot Corday Professor of Medicine and Cardiovascular Science
Director, Ahmanson-UCLA Cardiomyopathy Center
UCLA Division of Cardiology
UCLA Medical Center
Los Angeles, California
Wednesday, February 13, 2008 CME/CNE
Agenda Highlight:
ACC/AHA/SCAI Focused Guideline Update: PCI
Faculty:
Christopher P. Cannon, MD
Associate Professor of Medicine
Harvard Medical School
Senior Investigator, TIMI Study Group
Associate Physician, Cardiovascular Division
Brigham and Women’s Hospital
Boston, Massachusetts
Wednesday, January 16, 2008 CME/CNE
Agenda Highlight:
ACC/AHA Focused Guideline Update: STEMI
Faculty:
Gregg C. Fonarow, MD
Eliot Corday Professor of Medicine and Cardiovascular Science
Director, Ahmanson-UCLA Cardiomyopathy Center
UCLA Division of Cardiology
UCLA Medical Center
Los Angeles, California
Wednesday, November 14, 2007 CME/CNE
Agenda Highlight:
Report From the American Heart Association (AHA) Scientific Sessions 2007
Faculty:
Christopher P. Cannon, MD
Associate Professor of Medicine
Harvard Medical School
Senior Investigator, TIMI Study Group
Associate Physician, Cardiovascular Division
Brigham and Women’s Hospital
Boston, Massachusetts
Wednesday, January 17, 2007 CME/CNE
Agenda Highlight:
The Association of ACS Performance Measures With Outcomes
Faculty:
Gregg C. Fonarow, MD
Eliot Corday Professor of Medicine and Cardiovascular Science
Director, Ahmanson-UCLA Cardiomyopathy Center
UCLA Division of Cardiology
UCLA Medical Center
Los Angeles, California
Wednesday, January 17, 2007 CME/CNE
Agenda Highlight:
ACC/AHA ACS Guidelines for STEMI—Studies That May Impact the Guidelines Updates
Faculty:
Gregg C. Fonarow, MD
Eliot Corday Professor of Medicine and Cardiovascular Science
Director, Ahmanson-UCLA Cardiomyopathy Center
UCLA Division of Cardiology
UCLA Medical Center
Los Angeles, California
Wednesday, January 17, 2007 CME/CNE
Agenda Highlight:
Update of the ACC/AHA ACS Guidelines: UA/NSTEMI
Faculty:
Christopher P. Cannon, MD
Associate Professor of Medicine
Harvard Medical School
Senior Investigator, TIMI Study Group
Associate Physician, Cardiovascular Division
Brigham and Women’s Hospital
Boston, Massachusetts
Wednesday, January 17, 2007 CME/CNE
Agenda Highlight:
Report From Transcatheter Cardiovascular Therapeutics (TCT) 2007
Faculty:
Gregg C. Fonarow, MD
Eliot Corday Professor of Medicine and Cardiovascular Science
Director, Ahmanson-UCLA Cardiomyopathy Center
UCLA Division of Cardiology
UCLA Medical Center
Los Angeles, California
Wednesday, January 17, 2007 CME/CNE
Agenda Highlight:
Report From the European Society of Cardiology (ESC) Congress 2007
Faculty:
Gregg C. Fonarow, MD
Eliot Corday Professor of Medicine and Cardiovascular Science
Director, Ahmanson-UCLA Cardiomyopathy Center
UCLA Division of Cardiology
UCLA Medical Center
Los Angeles, California
Wednesday, January 17, 2007 CME/CNE
Agenda Highlight:
Report From the NCDR-ACTION Registry: Combining the Power and Resources of CRUSADE and NRMI
Faculty:
Gregg C. Fonarow, MD
Eliot Corday Professor of Medicine and Cardiovascular Science
Director, Ahmanson-UCLA Cardiomyopathy Center
UCLA Division of Cardiology
UCLA Medical Center
Los Angeles, California
Wednesday, January 17, 2007 CME/CNE
Agenda Highlight:
The American College of Cardiology’s Door to Balloon (D2B) Campaign: A New Alliance for Quality
Faculty:
Christopher P. Cannon, MD
Associate Professor of Medicine
Harvard Medical School
Senior Investigator, TIMI Study Group
Associate Physician, Cardiovascular Division
Brigham and Women’s Hospital
Boston, Massachusetts
Wednesday, January 17, 2007 CME/CNE
Agenda Highlight:
The American Heart Association’s Get With The Guidelines: New Guidelines, New Challenges
Faculty:
Gregg C. Fonarow, MD
Eliot Corday Professor of Medicine and Cardiovascular Science
Director, Ahmanson-UCLA Cardiomyopathy Center
UCLA Division of Cardiology
UCLA Medical Center
Los Angeles, California
Wednesday, January 17, 2007 CME/CNE
Agenda Highlight:
The AHA/ACC/SCAI/ACS/ADA Science Advisory on Prevention of Premature Discontinuation of Dual Antiplatelet Therapy in Patients With Coronary Artery Stents
Faculty:
Christopher P. Cannon, MD
Associate Professor of Medicine
Harvard Medical School
Senior Investigator, TIMI Study Group
Associate Physician, Cardiovascular Division
Brigham and Women’s Hospital
Boston, Massachusetts
Wednesday, January 17, 2007 CME/CNE
Agenda Highlight:
Highlights From the 56th Annual Scientific Session of the American College of Cardiology
Faculty:
Christopher P. Cannon, MD
Associate Professor of Medicine
Harvard Medical School
Senior Investigator, TIMI Study Group
Associate Physician, Cardiovascular Division
Brigham and Women’s Hospital
Boston, Massachusetts
Wednesday, December 6, 2006 CME/CNE
Agenda Highlight:
Highlights From the 2006 American Heart Association Scientific Sessions
Faculty:
Gregg C. Fonarow, MD
Eliot Corday Professor of Medicine and Cardiovascular Science
Director, Ahmanson-UCLA Cardiomyopathy Center
UCLA Division of Cardiology
UCLA Medical Center
Los Angeles, California
Wednesday, November 8, 2006 CME/CNE
Agenda Highlight:
Highlights From the 2006 Transcatheter Cardiovascular Therapeutics (TCT) Conference
Faculty:
Christopher P. Cannon, MD
Associate Professor of Medicine
Harvard Medical School
Senior Investigator, TIMI Study Group
Associate Physician, Cardiovascular Division
Brigham and Women’s Hospital
Boston, Massachusetts
Wednesday, October 11, 2006 CME/CNE
Agenda Highlight:
Diabetes and Metabolic Syndrome in Patients Hospitalized With CVD
Faculty:
Gregg C. Fonarow, MD
Eliot Corday Professor of Medicine and Cardiovascular Science
Director, Ahmanson-UCLA Cardiomyopathy Center
UCLA Division of Cardiology
UCLA Medical Center
Los Angeles, California
Wednesday, September 13, 2006 CME/CNE
Agenda Highlight:
Highlights from the World Congress of Cardiology 2006
Faculty:
Christopher P. Cannon, MD
Associate Professor of Medicine
Harvard Medical School
Senior Investigator, TIMI Study Group
Associate Physician, Cardiovascular Division
Brigham and Women’s Hospital
Boston, Massachusetts
Wednesday, August 16, 2006 CME/CNE
Agenda Highlight:
The 2006 AHA/ACC Secondary Prevention Guidelines: What Is New?
Faculty:
Gregg C. Fonarow, MD
Eliot Corday Professor of Medicine and Cardiovascular Science
Director, Ahmanson-UCLA Cardiomyopathy Center
UCLA Division of Cardiology
UCLA Medical Center
Los Angeles, California
Wednesday, July 12, 2006 CME/CNE
Agenda Highlight:
Reducing Time to Treatment in STEMI: Why Do Some Hospitals Succeed?
Faculty:
Christopher P. Cannon, MD
Associate Professor of Medicine
Harvard Medical School
Senior Investigator, TIMI Study Group
Associate Physician, Cardiovascular Division
Brigham and Women’s Hospital
Boston, Massachusetts
Wednesday, June 21, 2006 CME/CNE
Agenda Highlight:
2006 ACC/AHA Performance Measures for AMI (STEMI and NSTEMI)
Faculty:
Gregg C. Fonarow, MD
Eliot Corday Professor of Medicine and Cardiovascular Science
Director, Ahmanson-UCLA Cardiomyopathy Center
UCLA Division of Cardiology
UCLA Medical Center
Los Angeles, California
Wednesday, May 17, 2006 CME/CNE
Agenda Highlight:
Clinical Implications of Recent ACS Clinical Trials
Faculty:
Christopher P. Cannon, MD
Associate Professor of Medicine
Harvard Medical School
Senior Investigator, TIMI Study Group
Associate Physician, Cardiovascular Division
Brigham and Women’s Hospital
Boston, Massachusetts
Wednesday, April 19, 2006 CME/CNE
Agenda Highlight:
Preliminary Findings from the REACH Registry
Faculty:
Gregg C. Fonarow, MD
Eliot Corday Professor of Medicine and Cardiovascular Science
Director, Ahmanson-UCLA Cardiomyopathy Center
UCLA Division of Cardiology
UCLA Medical Center
Los Angeles, California
Wednesday, March 22, 2006 CME/CNE
Agenda Highlight:
Highlights from the ACC 2006 Scientific Session
Faculty:
Gregg C. Fonarow, MD
Eliot Corday Professor of Medicine and Cardiovascular Science
Director, Ahmanson-UCLA Cardiomyopathy Center
UCLA Division of Cardiology
UCLA Medical Center
Los Angeles, California
Wednesday, February 15, 2006 CME/CNE
Agenda Highlight:
Applying the New ACC/AHA Guidelines for Peripheral Arterial Disease
Faculty:
Christopher P. Cannon, MD
Associate Professor of Medicine
Harvard Medical School
Senior Investigator, TIMI Study Group
Associate Physician, Cardiovascular Division
Brigham and Women’s Hospital
Boston, Massachusetts
Wednesday, January 18, 2006 CME/CNE
Agenda Highlight:
Public Reporting of Quality-of-Care Measures and Pay for Performance: How Do they Impact Your Institution?
Faculty:
Christopher P. Cannon, MD
Associate Professor of Medicine
Harvard Medical School
Senior Investigator, TIMI Study Group
Associate Physician, Cardiovascular Division
Brigham and Women’s Hospital
Boston, Massachusetts
Wednesday, December 7, 2005 CME/CNE
Agenda Highlight:
Update on the 2005 AHA Scientific Sessions
Faculty:
Gregg C. Fonarow, MD
Eliot Corday Professor of Medicine and Cardiovascular Science
Director, Ahmanson-UCLA Cardiomyopathy Center
UCLA Division of Cardiology
UCLA Medical Center
Los Angeles, California
Wednesday, November 9, 2005 CME/CNE
Agenda Highlight:
Acute Management of MI: Hightlights from TCT 2005
Faculty:
Christopher P. Cannon, MD
Associate Professor of Medicine
Harvard Medical School
Senior Investigator, TIMI Study Group
Associate Physician, Cardiovascular Division
Brigham and Women’s Hospital
Boston, Massachusetts
Wednesday, October 19, 2005 CME/CNE
Agenda Highlight:
New ACS Clinical Trial Results Presented at the European Society of Cardiology (ESC) Congress 2005
Faculty:
Gregg C. Fonarow, MD
Eliot Corday Professor of Medicine and Cardiovascular Science
Director, Ahmanson-UCLA Cardiomyopathy Center
UCLA Division of Cardiology
UCLA Medical Center
Los Angeles, California
Wednesday, September 14, 2005 CME/CNE
Agenda Highlight:
The CRUSADE National Quality Improvement Initiative: 2005 Update
Faculty:
Gregg C. Fonarow, MD
Eliot Corday Professor of Medicine and Cardiovascular Science
Director, Ahmanson-UCLA Cardiomyopathy Center
UCLA Division of Cardiology
UCLA Medical Center
Los Angeles, California
Wednesday, August 10, 2005 CME/CNE
Agenda Highlight:
Cost-effectiveness of CVD Therapies: Which Therapies Provide Good Value?
Faculty:
Gregg C. Fonarow, MD
Eliot Corday Professor of Medicine and Cardiovascular Science
Director, Ahmanson-UCLA Cardiomyopathy Center
UCLA Division of Cardiology
UCLA Medical Center
Los Angeles, California
Wednesday, July 20, 2005 CME/CNE
Agenda Highlight:
Effective Strategies for Improving Adherence to the ACC/AHA Guidelines
Faculty:
Gregg C. Fonarow, MD
Eliot Corday Professor of Medicine and Cardiovascular Science
Director, Ahmanson-UCLA Cardiomyopathy Center
UCLA Division of Cardiology
UCLA Medical Center
Los Angeles, California
Wednesday, June 15, 2005 CME/CNE
Agenda Highlight:
Critical Pathways: An Emergency Department Perspective
Faculty:
Christopher P. Cannon, MD
Associate Professor of Medicine
Harvard Medical School
Senior Investigator, TIMI Study Group
Associate Physician, Cardiovascular Division
Brigham and Women’s Hospital
Boston, Massachusetts
Thursday, May 19, 2005 CME/CNE
Agenda Highlight:
Inflammation and CVD: Markers and Modifiers
Faculty:
Gregg C. Fonarow, MD
Eliot Corday Professor of Medicine and Cardiovascular Science
Director, Ahmanson-UCLA Cardiomyopathy Center
UCLA Division of Cardiology
UCLA Medical Center
Los Angeles, California
Wednesday, April 13, 2005 CME/CNE
Agenda Highlight:
Highlights from the 54th Annual Scientific Session of the ACC
Faculty:
Christopher P. Cannon, MD
Associate Professor of Medicine
Harvard Medical School
Senior Investigator, TIMI Study Group
Associate Physician, Cardiovascular Division
Brigham and Women’s Hospital
Boston, Massachusetts
Wednesday, March 16, 2005 CME/CNE
Agenda Highlight:
Risk Stratification of CVD Patients
Faculty:
Gregg C. Fonarow, MD
Eliot Corday Professor of Medicine and Cardiovascular Science
Director, Ahmanson-UCLA Cardiomyopathy Center
UCLA Division of Cardiology
UCLA Medical Center
Los Angeles, California
Thursday, September 16, 2004 CME/CNE
Agenda Highlight:
Critical Pathways for Acute Coronary Syndromes CME Teleconferences
Faculty:
Gregg C. Fonarow, MD
Eliot Corday Professor of Medicine and Cardiovascular Science
Director, Ahmanson-UCLA Cardiomyopathy Center
UCLA Division of Cardiology
UCLA Medical Center
Los Angeles, California
Wednesday, August 11, 2004 CME/CNE
Agenda Highlight:
Critical Pathways for Acute Coronary Syndromes CME Teleconferences
Faculty:
Christopher P. Cannon, MD
Associate Professor of Medicine
Harvard Medical School
Senior Investigator, TIMI Study Group
Associate Physician, Cardiovascular Division
Brigham and Women’s Hospital
Boston, Massachusetts
Tuesday, July 20, 2004 CME/CNE
Agenda Highlight:
Critical Pathways for Acute Coronary Syndromes CME Teleconferences
Faculty:
Gregg C. Fonarow, MD
Eliot Corday Professor of Medicine and Cardiovascular Science
Director, Ahmanson-UCLA Cardiomyopathy Center
UCLA Division of Cardiology
UCLA Medical Center
Los Angeles, California
Tuesday, June 15, 2004 CME/CNE
Agenda Highlight:
Critical Pathways for Acute Coronary Syndromes CME Teleconferences
Faculty:
Christopher P. Cannon, MD
Associate Professor of Medicine
Harvard Medical School
Senior Investigator, TIMI Study Group
Associate Physician, Cardiovascular Division
Brigham and Women’s Hospital
Boston, Massachusetts
Tuesday, May 25, 2004 CME/CNE
Agenda Highlight:
Critical Pathways for Acute Coronary Syndromes CME Teleconferences
Faculty:
Christopher P. Cannon, MD
Associate Professor of Medicine
Harvard Medical School
Senior Investigator, TIMI Study Group
Associate Physician, Cardiovascular Division
Brigham and Women’s Hospital
Boston, Massachusetts
Wednesday, April 28, 2004 CME/CNE
Agenda Highlight:
Critical Pathways for Acute Coronary Syndromes CME Teleconferences
Faculty:
Christopher P. Cannon, MD
Associate Professor of Medicine
Harvard Medical School
Senior Investigator, TIMI Study Group
Associate Physician, Cardiovascular Division
Brigham and Women’s Hospital
Boston, Massachusetts
Wednesday, March 24, 2004 CME/CNE
Agenda Highlight:
Critical Pathways for Acute Coronary Syndromes CME Teleconferences
Faculty:
Gregg C. Fonarow, MD
Eliot Corday Professor of Medicine and Cardiovascular Science
Director, Ahmanson-UCLA Cardiomyopathy Center
UCLA Division of Cardiology
UCLA Medical Center
Los Angeles, California
Wednesday, February 25, 2004 CME/CNE
Agenda Highlight:
Critical Pathways for Acute Coronary Syndromes CME Teleconferences
Faculty:
Christopher P. Cannon, MD
Associate Professor of Medicine
Harvard Medical School
Senior Investigator, TIMI Study Group
Associate Physician, Cardiovascular Division
Brigham and Women’s Hospital
Boston, Massachusetts
Wednesday, January 21, 2004 CME/CNE
Agenda Highlight:
Critical Pathways for Acute Coronary Syndromes CME Teleconferences
Faculty:
Gregg C. Fonarow, MD
Eliot Corday Professor of Medicine and Cardiovascular Science
Director, Ahmanson-UCLA Cardiomyopathy Center
UCLA Division of Cardiology
UCLA Medical Center
Los Angeles, California
Wednesday, December 17, 2003 CME/CNE
Agenda Highlight:
Critical Pathways for Acute Coronary Syndromes CME Teleconferences
Faculty:
Gregg C. Fonarow, MD
Eliot Corday Professor of Medicine and Cardiovascular Science
Director, Ahmanson-UCLA Cardiomyopathy Center
UCLA Division of Cardiology
UCLA Medical Center
Los Angeles, California
Wednesday, November 19, 2003 CME/CNE
Agenda Highlight:
Critical Pathways for Acute Coronary Syndromes CME Teleconferences
Faculty:
Christopher P. Cannon, MD
Associate Professor of Medicine
Harvard Medical School
Senior Investigator, TIMI Study Group
Associate Physician, Cardiovascular Division
Brigham and Women’s Hospital
Boston, Massachusetts
Wednesday, October 1, 2003 CME/CNE
Agenda Highlight:
Critical Pathways for Acute Coronary Syndromes CME Teleconferences
Faculty:
Gregg C. Fonarow, MD
Eliot Corday Professor of Medicine and Cardiovascular Science
Director, Ahmanson-UCLA Cardiomyopathy Center
UCLA Division of Cardiology
UCLA Medical Center
Los Angeles, California
Wednesday, October 1, 2003 CME/CNE
Agenda Highlight:
Critical Pathways for Acute Coronary Syndromes CME Teleconferences
Faculty:
Christopher P. Cannon, MD
Associate Professor of Medicine
Harvard Medical School
Senior Investigator, TIMI Study Group
Associate Physician, Cardiovascular Division
Brigham and Women’s Hospital
Boston, Massachusetts



This activity is part of the Strategies and Therapies for Reducing Ischemic and Vascular Events (STRIVE®) education initiative, a program of the Network for Continuing Medical Education (NCME).


This CME activity is co-provided by the Network for Continuing Medical Education and EduPro Resources LLC.

Supported by an educational grant from the Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership.